| Aug'19 | Aug'18 | |||||
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net income | ||||||
47,536 | 70,455 | |||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
7,644 | 7,672 | |||||
Amortization of deferred financing costs and debt discount | ||||||
1,352 | 1,312 | |||||
Stock compensation expense | ||||||
5,501 | 4,029 | |||||
Change in warrant liabilities | ||||||
0 | 0 | |||||
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | ||||||
533 | -2,848 | |||||
Gain on settlement of TRA liability | ||||||
1,534 | 0 | |||||
Unrealized (gain) loss on foreign currency transactions | ||||||
-452 | 97 | |||||
Deferred income taxes | ||||||
10,908 | -21,108 | |||||
Loss on disposal of property and equipment | ||||||
-6 | -128 | |||||
Changes in operating assets and liabilities, net of acquisition: | ||||||
Accounts receivable, net | ||||||
7,985 | -267 | |||||
Inventories | ||||||
8,272 | 1,081 | |||||
Prepaid expenses | ||||||
824 | -847 | |||||
Other current assets | ||||||
2,155 | -3,094 | |||||
Accounts payable | ||||||
4,734 | -3,603 | |||||
Accrued interest | ||||||
1,111 | 21 | |||||
Accrued expenses and other current liabilities | ||||||
13,961 | 1,962 | |||||
Other assets and liabilities | ||||||
74 | -12 | |||||
Net cash (used in) provided by operating activities | ||||||
73,042 | 61,038 | |||||
Investing activities | ||||||
Purchases of property and equipment | ||||||
1,037 | 1,770 | |||||
Proceeds from sale of property and equipment | ||||||
0 | 14 | |||||
Increase (Decrease) in Notes Receivables | ||||||
750 | 0 | |||||
Acquisition of business, net of cash acquired | ||||||
0 | -1,757 | |||||
Cash withdrawn from trust account | ||||||
0 | 0 | |||||
Net cash (used in) investing activities | ||||||
-1,787 | -3,513 | |||||
Financing activities | ||||||
Proceeds from option exercises | ||||||
706 | 120 | |||||
Issuance of common stock | ||||||
181 | 120 | |||||
Cash received from warrant exercises | ||||||
113,500 | 232 | |||||
Repurchase of common stock | ||||||
2,145 | 0 | |||||
Payment of TRA liability | ||||||
26,468 | 0 | |||||
Excess tax benefits of stock-based compensation | ||||||
0 | 0 | |||||
Payments of Financing Costs | ||||||
0 | 319 | |||||
Principal payments of long-term debt | ||||||
2,000 | 1,500 | |||||
Proceeds from issuance of private placement equity, net of issuance costs | ||||||
0 | 0 | |||||
Proceeds from Issuance of Long-term Debt | ||||||
0 | 0 | |||||
Payment of Conyers Park deferred equity issuance costs | ||||||
0 | 0 | |||||
Net cash provided by financing activities | ||||||
83,376 | -1,587 | |||||
Cash and cash equivalents | ||||||
Net (decrease) increase in cash | ||||||
154,631 | 55,938 | |||||
Effect of exchange rate on cash | ||||||
-261 | -468 | |||||
Supplemental disclosures of cash flow information | ||||||
Cash paid for interest | ||||||
11,164 | 11,218 | |||||
Cash paid for taxes | ||||||
7,451 | 4,577 | |||||